Vitamin E therapy results in a reduction in HDL function in individuals with diabetes and the haptoglobin 2-1 genotype
about
Haptoglobin genotype and its role in determining heme-iron mediated vascular diseasePathophysiology and Treatments of Oxidative Injury in Ischemic Stroke: Focus on the Phagocytic NADPH Oxidase 2Vitamins and type 2 diabetes mellitusPharmacogenomic interaction between the Haptoglobin genotype and vitamin E on atherosclerotic plaque progression and stability.Long-term vitamin E supplementation reduces atherosclerosis and mortality in Ldlr-/- mice, but not when fed Western style diet.Haptoglobin is required to prevent oxidative stress and muscle atrophy.HDL dysfunction in diabetes: causes and possible treatments.High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (multi-ethnic study of atherosclerosis).High Density Lipoprotein and it's DysfunctionHaptoglobin genotype and its role in diabetic cardiovascular disease.Patient selection and vitamin E treatment in diabetes mellitus.Effect of vitamin E supplementation on HDL function by haptoglobin genotype in type 1 diabetes: results from the HapE randomized crossover pilot trial.Vitamin E and diabetic nephropathy in mice model and humans.Influence of Vitamins on Secondary Reactive Oxygen Species Production in Sera of Patients with Resectable NSCLCPrecision Healthcare of Type 2 Diabetic Patients Through Implementation of Haptoglobin Genotyping
P2860
Q26852155-1668622D-60BE-4658-998F-31D611B1FC44Q27005956-E274F908-0690-42E4-89F5-9D38E02568A5Q27022122-1E6DDD16-5553-49A6-A544-0C17A4FE990AQ27332892-4F564029-C2B8-4255-970A-7FD6C367537FQ33637932-797585A4-B233-4217-8DF7-7F905F89C1EFQ33800519-AE6B089B-24FF-4213-803C-FE948573F7F1Q35904110-9AEB1D27-7694-48C4-97C2-8FA3C81D3AA9Q36139932-B4FBFF38-B618-409A-8AAD-063D6C841C3DQ36150462-AAECDEA5-7BD2-436D-961A-2F00818831E2Q36678611-427FE7BA-0697-4A35-A2EE-B939D56B26A9Q36736431-BF998454-FFC8-44DE-A0A0-C788F7906C8BQ36782847-76EC8DEC-850F-4656-910E-0986D0989A61Q37322007-55A64437-3818-449F-B636-B60D39C055D0Q42226829-B57B12B2-B128-44FB-944D-1C19385E1269Q58553441-27C64687-DE43-4768-8DE1-FBCEF0B14F62
P2860
Vitamin E therapy results in a reduction in HDL function in individuals with diabetes and the haptoglobin 2-1 genotype
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Vitamin E therapy results in a ...... d the haptoglobin 2-1 genotype
@ast
Vitamin E therapy results in a ...... d the haptoglobin 2-1 genotype
@en
Vitamin E therapy results in a ...... d the haptoglobin 2-1 genotype
@nl
type
label
Vitamin E therapy results in a ...... d the haptoglobin 2-1 genotype
@ast
Vitamin E therapy results in a ...... d the haptoglobin 2-1 genotype
@en
Vitamin E therapy results in a ...... d the haptoglobin 2-1 genotype
@nl
prefLabel
Vitamin E therapy results in a ...... d the haptoglobin 2-1 genotype
@ast
Vitamin E therapy results in a ...... d the haptoglobin 2-1 genotype
@en
Vitamin E therapy results in a ...... d the haptoglobin 2-1 genotype
@nl
P2093
P2860
P1433
P1476
Vitamin E therapy results in a ...... d the haptoglobin 2-1 genotype
@en
P2093
Andrew P Levy
Avery Schwartz
Dan Farbstein
Doron Moskovich
Hagai Tavori
Hilla Lee Viener
Ido Barkay
Jacob Vaya
Michael Star
P2860
P304
P356
10.1016/J.ATHEROSCLEROSIS.2011.06.005
P407
P50
P577
2011-06-13T00:00:00Z